SIMBHALSNSESimbhaoli Sugars LimitedMediumNeutral
Announced Fri, 29 May · 19:25 IST

Simbhaoli Sugars Limited has submitted to the Exchange, Consolidated Unaudited Financial results for the period ended 30th June 2025.

Qualified OpinionAdverse OpinionGoing ConcernPat NegativeDebt Equity ThresholdNegative Operating CashflowResults View source PDF

SIMBHALS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
prior close
₹7.97
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0
Up moveDown movePending
AI summary

Simbhaoli Sugars Limited, under Corporate Insolvency Resolution Process (CIRP) since July 2024, held an IRP meeting on May 29, 2026. The auditors issued an ADVERSE OPINION on Consolidated Q1 FY26 (June 30, 2025) results showing Total Income of ₹23,392.40 Lakhs and Net Loss of ₹2,243.24 Lakhs. Key concerns include: material subsidiary SPPL issued a Disclaimer of Opinion citing going concern doubts due to turbine breakdown and losses; subsidiary ICCPL issued Adverse Opinion citing disputed receivables and deferred tax asset issues; the holding company made no provision for interest on borrowings of ₹8,360.27 Lakhs for the quarter with cumulative unprovided interest of ₹1,83,389.90 Lakhs; and unprovided interest on cane dues claims of ₹12,163.25 Lakhs. The auditors highlighted that the company's net worth is fully eroded, current liabilities exceed current assets, and there are multiple payment defaults. The company also appointed Cost Auditor (M/s Cheena & Associates) and Secretarial Auditor (M/s Amit Gupta & Associates) for FY 2025-26.

Likely market impact

The stock remains highly speculative due to ongoing CIRP proceedings, adverse auditor opinions, and material misstatements in financial results. Shareholders face extreme risk as the company's ability to continue as a going concern is in serious doubt, pending NCLAT's final decision on whether CIRP will resume.